UY28667A1 - FORM OF TRANSDERMAL, LIQUID OR SEMISOLID ADMINISTRATION CONTAINING ACTIVE SUBSTANCE SENSITIVE TO LIGHT, STABLE TO ULTRAVIOLET RAYS. - Google Patents
FORM OF TRANSDERMAL, LIQUID OR SEMISOLID ADMINISTRATION CONTAINING ACTIVE SUBSTANCE SENSITIVE TO LIGHT, STABLE TO ULTRAVIOLET RAYS.Info
- Publication number
- UY28667A1 UY28667A1 UY28667A UY28667A UY28667A1 UY 28667 A1 UY28667 A1 UY 28667A1 UY 28667 A UY28667 A UY 28667A UY 28667 A UY28667 A UY 28667A UY 28667 A1 UY28667 A1 UY 28667A1
- Authority
- UY
- Uruguay
- Prior art keywords
- light
- transdermal
- administration
- active substance
- semisolid
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Formas de administración farma´ceuticas semisólidas o líquidas para uso transdérmico que contiene una sustancia activa sensible a la luz UV y por lo menosuna sustancia auxiliar (absorbedor de luz UV) que se encuentra presente en la forma de administración en forma disuelta o dispersa. Ventajosamente, la forma de administración de la invención se relaciona con geles transdérmicos, cuya base está formada por agua, alcohol, por lo menos un polímero formador de gel y si fuera necesario, otros componentes. En esta forma de administración se minimizan los efectos secundarios daninos para el usuario que pueden resultar de la protección UV propuesta, como p. ej. la absorción de protector de luz por el cuerpo.Semi-solid or liquid pharmaceutical administration forms for transdermal use containing an active substance sensitive to UV light and at least one auxiliary substance (UV light absorber) that is present in the form of administration in dissolved or dispersed form. Advantageously, the method of administration of the invention relates to transdermal gels, whose base is formed by water, alcohol, at least one gel-forming polymer and, if necessary, other components. In this form of administration, harmful side effects to the user that may result from the proposed UV protection, such as p. ex. The absorption of light protector by the body.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UY28667A UY28667A1 (en) | 2004-12-10 | 2004-12-10 | FORM OF TRANSDERMAL, LIQUID OR SEMISOLID ADMINISTRATION CONTAINING ACTIVE SUBSTANCE SENSITIVE TO LIGHT, STABLE TO ULTRAVIOLET RAYS. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UY28667A UY28667A1 (en) | 2004-12-10 | 2004-12-10 | FORM OF TRANSDERMAL, LIQUID OR SEMISOLID ADMINISTRATION CONTAINING ACTIVE SUBSTANCE SENSITIVE TO LIGHT, STABLE TO ULTRAVIOLET RAYS. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY28667A1 true UY28667A1 (en) | 2005-07-29 |
Family
ID=38813016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY28667A UY28667A1 (en) | 2004-12-10 | 2004-12-10 | FORM OF TRANSDERMAL, LIQUID OR SEMISOLID ADMINISTRATION CONTAINING ACTIVE SUBSTANCE SENSITIVE TO LIGHT, STABLE TO ULTRAVIOLET RAYS. |
Country Status (1)
| Country | Link |
|---|---|
| UY (1) | UY28667A1 (en) |
-
2004
- 2004-12-10 UY UY28667A patent/UY28667A1/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28189A1 (en) | TRANSDERMAL THERAPEUTIC SYSTEM STABLE TO UV RAYS. | |
| CL2012002844A1 (en) | Compounds derived from chromen-2-one; pharmaceutical composition that includes them; and its use in the treatment of a proliferative cell disorder such as cancer (divisional application No. 311-07). | |
| UY26496A1 (en) | PHARMACEUTICAL COMPOSITIONS PROVIDING POTENTIAL DRUG CONCENTRATIONS | |
| DE69923786D1 (en) | THIN POLYMER FILM AS MEDICAMENT RESERVOIR | |
| SV2002000250A (en) | DRUG DOSE FORMULA OPERATED BY HYDROGEL REF. PC10818AJTB / BB | |
| ES2185817T3 (en) | ORAL PHARMACEUTICAL DOSAGE FORMS THAT INCLUDE AN INHIBITOR OF THE PUMPS OF PROTONS AND AN AGENT ANTICIDE OR ALGINATE. | |
| ATE509617T1 (en) | PHENYTOIN FORMULATIONS AND THEIR USES IN WOUND HEALING | |
| AR097045A2 (en) | TRANSDERMAL THERAPEUTIC SYSTEM | |
| SV2008002963A (en) | TRIAZOLOPIRIDAZINAS AS MODULATORS OF THYROSINE KINASE REFERENCE CROSSED WITH RELATED APPLICATIONS REF. PRD2584SV | |
| ES2156024T3 (en) | SILICATED DERIVATIVES OF BENZO-X-AZOLES FILTERS, PHOTOPROTECTOR COSMETIC COMPOSITIONS CONTAINING THEM AND USES. | |
| SV1999000016A (en) | DERIVATIVES OF 2- (PURIN-9-IL-TETRAHIDROFURAN-3,4-DIOL REF. PG3443 / SV | |
| ECSP067027A (en) | FOAM WATERPROOF FORMULATIONS IN FOAM FOR PLANTS PROTECTION | |
| ATE422873T1 (en) | COSMETIC OR DERMATOLOGICAL PREPARATIONS WITH EFFECTIVE LIGHT PROTECTION | |
| UY31403A1 (en) | "NOVEDOUS DERIVATIVES OF ({((3-Methylphenyl) -2H-TETRAZOL-5-IL) -ETOXI} -4H-1,2,4-TRIAZOL-3-IL), PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND MEDICAL USE OF THE SAME" . | |
| PA8555501A1 (en) | SUBSTITUTED BENZIMIDAZOL COMPOUNDS AND THEIR USE FOR CANCER TREATMENT | |
| ECSP066689A (en) | FORM OF TRANSDERMAL, LIQUID OR SEMISOLID ADMINISTRATION CONTAINING ACTIVE SUBSTANCE SENSITIVE TO LIGHT, STABLE TO ULTRAVIOLET RAYS | |
| AR020781A1 (en) | USE OF OPHTHALM COMPOSITION | |
| UY28667A1 (en) | FORM OF TRANSDERMAL, LIQUID OR SEMISOLID ADMINISTRATION CONTAINING ACTIVE SUBSTANCE SENSITIVE TO LIGHT, STABLE TO ULTRAVIOLET RAYS. | |
| CU20060115A7 (en) | FORM OF TRANSDERMAL, LIQUID OR SEMISOLID ADMINISTRATION CONTAINING ACTIVE SUBSTANCE SENSITIVE TO LIGHT, STABLE TO ULTRAVIOLET RAYS | |
| GT200600183A (en) | SOLID TRANSDERMAL THERAPEUTICE SYSTEM WITH UV ABSORBER. | |
| PA8454001A1 (en) | DOSAGE FORMS OF SERTRALINE ENCAPSULATED SOLUTION | |
| AR023100A1 (en) | METHOD TO INCREASE STABILITY DURING STORAGE AND / OR IN THE APPLICATION OF PHOTOSENSIBLE THERAPEUTIC SYSTEMS OR THEIR COMPONENTS AND FORM OF ADMINISTRATION OF THE SAME | |
| ES2171591T3 (en) | NEW METHOD OF DOSAGE OF HYDROXOCOBALAMINE AND ITS USE IN THE CYANIDE POISONING. | |
| AR017304A1 (en) | AN ARTICLE WITH ABSORBENT STRUCTURE IN LAYERS WITH BASE WEIGHT BY ZONES | |
| DK1660054T3 (en) | Ergoline-containing agent for transdermal application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20150605 |